uniQure N.V.
QURE
Jodie situation report
uniQure N.V.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 10 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 2 directly disclosed connections are confirming.
- QURE's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if QURE's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind QURE
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
HTGCHercules Capital, Inc.lenderMar 2, 2026 ▾
“Hercules Loan Amendment In September 2025, we entered into a $175.0 million senior secured term loan facility (the “2025 Amended Facility”) with Hercules Capital, Inc.”
Depended on by
CRSPCRISPR Therapeutics AGcompetitorFeb 12, 2026 ▾
“These companies may also serve as competitive threats and include 4D Molecular Therapeutics, AskBio, Passage Bio, Sarepta Therapeutics, UniQure, and Voyager Therapeutics.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 5 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
QURE is currently a Early Follower in the organic co-movement group Mixed Sector Themes. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 2 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for QURE; it is not active in the latest market snapshot.